Galapagos garners $9.7M milestone; FDA approves new Roche test for hep C drugs;

 @FierceBiotech: Popular yesterday: Theravance: Biotech's big coming-of-age story. Editor's Corner | Follow @FierceBiotech

@JohnCFierce: TauRx adds $10.5M to its unconventional trove of Alzheimer's PhIII cash. News | Follow @JohnCFierce

@RyanMFierce: Engineering issues have stymied the mini DNA sequencer from Oxford Bio. Blogger says the tech chief is angry: Report | Follow @RyanMFierce

> Galapagos says it earned a $9.7 million milestone from Servier for its alliances on osteoarthritis and oncology. Release

> The FDA has approved Roche's ($RHHBY) new viral load test to evaluate response to hepatitis C therapies. Release | More from FierceMedicalDevices

> Roche and BioLamina inked an R&D deal to jointly develop new cell culture systems for various applications, including stem cell research. Release

Pharma News

@FiercePharma: Longtime Roche chairman Franz Humer is stepping aside. Who's up next? More | Follow @FiercePharma

@EricPFierce: Pfizer building a plant in Saudi Arabia as MENA area becomes of more interest to Big Pharma. Story | Follow @EricPFierce

> FDA panel looks askance at calcitonin bone drugs. Report

> Lilly CEO blasts Europe's drug-pricing moves. Story

> Par to pay $45M for off-label Megace marketing. News

Medical Device News

 @FierceMedDev: Report: Life Tech may have found a buyer after all. Story | Follow @FierceMedDev

 @MarkHFierce: Royalty financing may not be new, but it's novel for the medical device world. More | Follow @MarkHFierce

 @DamianFierce: Boston Scientific is holding back some data on Watchman, and market watchers are a little spooked. Report | Follow @DamianFierce

> GI Dynamics revs up anti-obesity device for Brazilian market. Item

> Saladax secures $22.4M from Chinese pharma giant. Report

Biomarkers News

> Advanced Cell Diagnostics enables cancer immunotherapy biomarker work. Story

> Australian team builds depression blood test around quinolinic acid. More

> Biomarker shines a light on new pathway to target neuroblastoma. Report

> Scripps scientists spot tropical disease marker in urine. Article

> Ignyta, Lieden University team on RA biomarker research. Item

Drug Delivery News

@MichaelGFierce: Yale researchers improve lupus drug with nanogel delivery. More | Follow @MichaelGFierce

> Actium BioSystems puts the heat on cancer with hyperthermic delivery. Report

> Mercator micro-infusion drug delivery catheter snags CE mark. News

> Combo drug, Dx nanomedicine deliver cancer-fighting payload. Article

> West launches intradermal adapter for shallow injections. Item

And Finally… A team led by Rice physicist Ching-Hwa Kiang says that stresses in the flow of small blood vessels can change the shape of a common protein for up to 5 hours, significantly raising the risk of blood clots. The team will hunt for more information as it looks for new therapies to reduce the risk of blood clots. Release


Suggested Articles

UCB’s bispecific antibody recently beat Johnson & Johnson’s Stelara at clearing psoriasis symptoms, and now it has bested AbbVie’s Humira, too.

FDA staff took the action in response to cases of early growth plate closure in children on the retinoic acid receptor gamma agonist.

The CTAD presentation cleared up some questions about the data set without delivering a telling blow for either side of the debate.